Heart Disease Clinical Trials in New York

Showing 181-200 of 507 trials

REDUCE LAP-HFREF TRIAL

NCT03093961

The objective of this pilot study is to evaluate the safety and performance of implanting the IASD® System II in Heart Failure patients with reduced ejection fraction and elevated left sided filling pressures, who remain symptomatic despite Guideline Directed Medical Therapy (GDMT).

Heart Failure

Corvia Medical10 participantsStarted Mar 2017

New York, New York, United States • New Lambton Heights, New South Wales, Australia • Sydney, Australia +1 more locations

UNKNOWN< 1 mile

Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF

NCT05865197

Sensorum Health (Sensorum) is conducting a pilot study to determine if Sensorum's proprietary passive sensor network can be used to identify signals of early health decompensation in subjects prior to a hospitalization for chronic disease exacerbation or other ambulatory care sensitive conditions. Successful early detection would provide a window of opportunity to intervene outside of the acute setting in future interventional studies.

CHFCongestive Heart Failure

Sensorum Health Inc.20 participantsStarted Nov 2022

New York, New York, United States

COMPLETEDNA< 1 mile

A Study to EXhibit Percutaneous Coronary Artery Dilatation With Non-Slip Element Balloon

NCT04985773

The objective of this study is to evaluate safety and effectiveness of the Lacrosse NSE ALPHA coronary dilatation catheter during PCI in subjects with stenotic coronary arteries.

Coronary StenosisCoronary Artery StenosisIn-stent Restenosis

Infraredx200 participantsStarted Dec 2021

Palo Alto, California, United States • Lexington, Kentucky, United States • Maplewood, Minnesota, United States +7 more locations

REDUCE LAP-HFREF TRIAL

Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF

A Study to EXhibit Percutaneous Coronary Artery Dilatation With Non-Slip Element Balloon

Heart Disease Trials in Other Cities

Congenital Heart Disease: Impact on Learning and Development in Down Syndrome (CHILD-DS)

Effect of Evolocumab on Coronary Plaque Characteristics

Early Revascularization in Stable Ischemic Heart Disease Using P.E.T. Imaging

Patient Centered Machine Learning Model for Bleeding and Ischemic Risk

ANTHEM-HFrEF Pivotal Study

Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial

Clinical Use Cases Assessment of the Gabi System in Young Children With Underlying Medical Conditions (BRIDGE Study)

Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency

Impact of Beta-blockers on Physical Function in HFpEF

Safe Surveillance of PCI Under Mechanical Circulatory Support With the Saranas Early Bird Bleed Monitoring System

Primary Prevention of Cardiovascular Disease Among Female Hospital Employees: The Heart Smart for Women Intervention

ELUCIDATE FFRct Study

Comparative Effectiveness of Entresto (Sacubitril/Valsartan) Versus ACEi/ARB in de Novo Heart Failure Patients

A Study Using Surveys to Learn More About Treatment With Steroidal Mineralocorticoid Receptor Antagonists, How They Are Used, What Side Effects They Have, and How Satisfied People Who Receive Them Are in the US

A Clinical Trial to Confirm Safety & Effectiveness of the SYNERGY 4.50 mm and 5.00 mm Stent for Treatment of Atherosclerotic Lesion(s)

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

Resynchronization/Defibrillation for Ambulatory Heart Failure Trial

Other Conditions in New York